RLS is now a part of Telix Pharmaceuticals!Read More +

X

All Resources

Your Guide to Understanding USP General Chapter <825> Radiopharmaceuticals – Preparation, Compounding, Dispensing and Repackaging

Radiopharmaceuticals represent a unique class of drug products where compounding and other handling activities include the use of radionuclide generators, the preparation of commercially manufactured radiopharmaceutical kits, the dilution of FDA-approved multi-dose vials, the labeling of human blood products with radionuclides, the preparation of patient-specific radiopharmaceutical doses and more. These […]

April 8, 2024
Read More

The Vital Partnership Between Radiopharmaceutical Developers and Radiopharmacies

Radiopharmaceuticals represent a burgeoning frontier in modern medicine, ushering in a new era of diagnostic and therapeutic potential powered by the principles of nuclear science. While the medical application of radiation dates back over a century, the recent advancements and increasing interest in radiopharmaceuticals have marked the beginning of a […]

April 4, 2024
Read More

The Supply and Availability of Radiopharmaceuticals

These medical isotope-fueled compounds are being used for the diagnosis and treatment of cancer, neurological disorders, and cardiovascular disease.

August 25, 2023
Read More

RADIOPHARMACY NETWORK RLS ANNOUNCES EXECUTIVE APPOINTMENTS IN SALES AND HUMAN RESOURCES

Recent Hires Come as Leading Nuclear Pharmacy Network Continues to Expand Capabilities, Enter New Markets and Partner with Industry Pioneers

June 22, 2023
Read More

RLS AND SOFIE ENTER STRATEGIC PARTNERSHIP FOR DISTRIBUTION OF NUCLEAR MEDICINE DOSES FOR PATIENTS

SOFIE to Manufacture Batches, RLS to Compound and Distribute to SOFIE Customers, Improving Continuum of Care for Patients

June 21, 2023
Read More

RLS APPOINTS GLENN SULLIVAN AS DIRECTOR OF REGULATORY AFFAIRS

New Appointment Marks Latest in RLS’s Commitment to Best-in-Class Regulation as Radiopharmacy Network Continues to Scale for Long-Term Growth

June 13, 2023
Read More

SpectronRx and RLS Team Up to Give the Radiopharmaceutical Pipeline and Supply Chain a Much-Needed Boost

Marks Latest Step in RLS Expansion into Oncology & Work to Create an Unbroken Chain of Patient Care from Clinical Trial to Commercial Supply

June 7, 2023
Read More

RLS Awarded Radiopharmaceutical Products (Distributor) Agreement with Premier, Inc.

LAKE ZURICH, IL., June 5, 2023 /PRNewswire/ — RLS (USA), Inc. (Radioisotope Life Sciences), the third-largest nuclear medicine pharmacy network in the US, has been awarded a national group purchasing agreement for the distribution of Radiopharmaceutical Products with Premier, Inc, a leading healthcare improvement company headquartered in Charlotte, North Carolina. […]

June 5, 2023
Read More

RLS & Evergreen Partnership for Drug Candidate OCTEVY™

Expands RLS Capabilities and Offerings across the US, Begins to Establish Commercial Footprint for Evergreen

May 18, 2023
Read More

QSAM Biosciences and RLS Announce Clinical and Commercial Supply Agreement for Promising Clinical-Stage Metastatic and Primary Bone Cancer Treatment, CycloSam

Partnership is Latest in Series of RLS Efforts to Expand Industry-Leading CDMO Business and Clinical Trial Capability with Radiopharmaceutical Partners Across U.S.

May 16, 2023
Read More